DBVT (STOCKS)
DBV Technologies S.A.
$22.670000
-1.130000 (-4.75%)
Prev close: $23.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Daniel Tassé
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,404.20M
- Employees
- 117
- P/E (TTM)
- -4.31
- P/B (TTM)
- 12.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
3
Buy
1
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.24 | $-0.25 | +0.0125 | +4.95% |
|
Jun 2025 (Q2)
|
$-0.31 | $-0.33 | +0.0233 | +6.99% |
|
Jun 2024 (Q2)
|
$-0.34 | $-0.20 | -0.1380 | -68.32% |
|
Mar 2024 (Q1)
|
$-0.28 | $-0.31 | +0.0331 | +10.57% |
Financial Statements
| Revenues | $5.50M |
| Benefits Costs and Expenses | $130.51M |
| Costs And Expenses | $130.51M |
| Operating Expenses | $131.37M |
| Research and Development | $102.70M |
| Other Operating Expenses | $28.67M |
| Operating Income/Loss | -$125.87M |
| Income/Loss From Continuing Operations After Tax | -$125.13M |
| Income/Loss From Continuing Operations Before Tax | -$125.01M |
| Income Tax Expense/Benefit | $124.00K |
| Net Income/Loss | -$125.13M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$125.13M |
| Net Income/Loss Available To Common Stockholders, Basic | -$125.13M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.03 |
| Diluted Earnings Per Share | -$1.03 |
| Basic Average Shares | 374,713,395 |
| Diluted Average Shares | 374,713,395 |
| Assets | $110.50M |
| Current Assets | $88.88M |
| Prepaid Expenses | $3.07M |
| Other Current Assets | $85.81M |
| Noncurrent Assets | $21.61M |
| Fixed Assets | $10.54M |
| Intangible Assets | $21.00K |
| Other Non-current Assets | $11.06M |
| Liabilities | $57.64M |
| Current Liabilities | $49.49M |
| Noncurrent Liabilities | $8.16M |
| Equity | $52.85M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $52.85M |
| Liabilities And Equity | $110.50M |
| Net Cash Flow From Operating Activities | -$98.26M |
| Net Cash Flow From Operating Activities, Continuing | -$98.26M |
| Net Cash Flow From Investing Activities | $139.00K |
| Net Cash Flow From Investing Activities, Continuing | $139.00K |
| Net Cash Flow From Financing Activities | $117.80M |
| Net Cash Flow From Financing Activities, Continuing | $117.80M |
| Net Cash Flow | $19.68M |
| Net Cash Flow, Continuing | $19.68M |
| Comprehensive Income/Loss | -$121.95M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$121.95M |
| Other Comprehensive Income/Loss | -$8.03M |